Biochemical Reagent
-
BA7841 IDO-IN-6Summary: IDO-IN-6 (NLG-1486) is an indoleamine-2,3-dioxygenase inhibitor. - BA7842 NLG802Summary: NLG802 is a precursor of indoximod.
- BA7843 IDO-IN-13Summary: IDO-IN-13 is a potent inhibitor.
- BA7844 Roxyl-9Summary: An IDO1 (Indoleamine2,3-dioxygenase1) inhibitor.
- BA7845 CAY10581Summary: CAY10581 is a pyranaphthoquinone derivative.
-
BA7847 VorasidenibSummary: Vorasidenib (AG-881) is an orally available, brain-permeable, second-generation dual inhibitor of mutant isocitrate dehydrogenase 1 and 2. - BA7848 BAY-1436032Summary: A novel pan-mutant isocitrate dehydrogenase 1 inhibitor.
- BA7849 GSK321Summary: GSK321 is a potent inhibitor of the mutant isocitrate dehydrogenase 1 enzyme.
- BA7850 OlutasidenibSummary: Olutasidenib (FT-2102) is an orally active, blood-brain barrier-crossing, selective and potent inhibitor of isocitrate dehydrogenase.
- BA7851 IDH-305Summary: IDH-305 is an oral, mutation-selective and brain-permeable inhibitor targeting the (R132) mutation.